Related Experiment Video
Updated: Jul 11, 2026
05:33
Ear Plaster Therapy as a Safe and Effective Treatment for Gestational Vomiting
Published on: August 4, 2023
Review on hyperemesis gravidarum
Siti Khadijah Ismail1, Louise Kenny
1Cork University Maternity Hospital, Wilton, Cork, Ireland. sitikhadijahismail@yahoo.co.uk
Best Practice & Research. Clinical Gastroenterology
|September 25, 2007
Summary
Severe nausea and vomiting in pregnancy, known as hyperemesis gravidarum, affects a small percentage of pregnancies. This review covers its causes, complications, and management.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
Background:
- Hyperemesis gravidarum (HG) is a severe form of nausea and vomiting during pregnancy.
- It affects 0.3-2% of pregnancies and has a complex, multifactorial cause.
Purpose of the Study:
- To review the current literature on hyperemesis gravidarum.
- To cover clinical manifestations, diagnosis, epidemiology, etiology, complications, and management.
Main Methods:
- Literature review of current research on hyperemesis gravidarum.
- Synthesis of information on clinical presentation, diagnosis, and etiology.
- Analysis of maternal and fetal complications and evidence-based treatments.
Main Results:
- HG presents with intractable nausea and vomiting.
- The etiology is multifactorial, involving various contributing factors.
- Complications can affect both the mother and the fetus.
Conclusions:
- Effective management strategies for hyperemesis gravidarum are based on current evidence.
- Understanding the epidemiology and etiology is crucial for diagnosis and treatment.
- This review provides a comprehensive overview for healthcare professionals.
Related Concept Videos
01:22Pathophysiology of Vomiting
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through interaction...
01:21Hyperosmolar Hyperglycemic State
Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...
01:29Gastroesophageal Reflux Disease II: Clinical Features and Management
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
01:23Gastritis III: Clinical Manifestations and Management
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
01:30Acute Pancreatitis II: Clinical Manifestations and Management
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...